These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16876609)

  • 1. Quantification of the regional cerebral blood flow and vascular reserve in moyamoya disease using split-dose iodoamphetamine I 123 single-photon emission computed tomography.
    Honda M; Ezaki Y; Kitagawa N; Tsutsumi K; Ogawa Y; Nagata I
    Surg Neurol; 2006 Aug; 66(2):155-9; discussion 159. PubMed ID: 16876609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of cerebral hemodynamics in childhood moyamoya disease using a quantitative and a semiquantitative IMP-SPECT study.
    Saito N; Nakagawara J; Nakamura H; Teramoto A
    Ann Nucl Med; 2004 Jun; 18(4):323-31. PubMed ID: 15359926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-course analysis of brain perfusion single photon emission computed tomography using a three-dimensional stereotactic region-of-interest template in patients with moyamoya disease.
    Marushima A; Tsurushima H; Suzuki K; Nakai Y; Nemoto H; Matsumura A
    World Neurosurg; 2011; 76(3-4):304-10. PubMed ID: 21986429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral blood flow study in patients with moyamoya disease evaluated by IMP SPECT.
    Hoshi H; Ohnishi T; Jinnouchi S; Futami S; Nagamachi S; Kodama T; Watanabe K; Ueda T; Wakisaka S
    J Nucl Med; 1994 Jan; 35(1):44-50. PubMed ID: 8271059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral hemodynamics and metabolism in adult moyamoya disease: comparison of angiographic collateral circulation.
    Piao R; Oku N; Kitagawa K; Imaizumi M; Matsushita K; Yoshikawa T; Takasawa M; Osaki Y; Kimura Y; Kajimoto K; Hori M; Hatazawa J
    Ann Nucl Med; 2004 Apr; 18(2):115-21. PubMed ID: 15195758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive method for mapping CVR in moyamoya disease using ASL-MRI.
    Noguchi T; Kawashima M; Nishihara M; Egashira Y; Azama S; Irie H
    Eur J Radiol; 2015 Jun; 84(6):1137-43. PubMed ID: 25816991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of cerebral hemodynamics before and after revascularization in patients with occlusive cerebrovascular disease by means of quantitative IMP-SPECT with double-injection protocol.
    Ueno M; Nishizawa S; Toyoda H; Shimono T; Miyamoto S; Hashimoto N; Konishi J
    Ann Nucl Med; 2001 Jun; 15(3):209-15. PubMed ID: 11545190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications of the cortical hyperintensity belt sign in fluid-attenuated inversion recovery images after bypass surgery for moyamoya disease.
    Hamano E; Kataoka H; Morita N; Maruyama D; Satow T; Iihara K; Takahashi JC
    J Neurosurg; 2017 Jan; 126(1):1-7. PubMed ID: 26894456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease: a serial single photon emission CT/positron emission tomography study.
    Uchino H; Kuroda S; Hirata K; Shiga T; Houkin K; Tamaki N
    Stroke; 2012 Oct; 43(10):2610-6. PubMed ID: 22871684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diastolic blood pressure influences cerebrovascular reactivity measured by means of 123I-iodoamphetamine brain single photon emission computed tomography in medically treated patients with occlusive carotid or middle cerebral artery disease.
    Kimura Y; Oku N; Kajimoto K; Katoh H; Tanaka MR; Takasawa M; Imaizumi M; Kitagawa K; Hori M; Hatazawa J
    Ann Nucl Med; 2006 Apr; 20(3):209-15. PubMed ID: 16715952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral hemodynamic disturbance in dural arteriovenous fistula with retrograde leptomeningeal venous drainage: a prospective study using (123)I-iodoamphetamine single photon emission computed tomography.
    Kanemaru K; Kinouchi H; Yoshioka H; Yagi T; Wakai T; Hashimoto K; Fukumoto Y; Umeda T; Onishi H; Nishiyama Y; Horikoshi T
    J Neurosurg; 2015 Jul; 123(1):110-7. PubMed ID: 25859803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial transit artifacts observed by arterial spin labeling in Moyamoya disease.
    Ukai R; Mikami T; Nagahama H; Wanibuchi M; Akiyama Y; Miyata K; Mikuni N
    J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105058. PubMed ID: 32807463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which CT perfusion parameter best reflects cerebrovascular reserve?: correlation of acetazolamide-challenged CT perfusion with single-photon emission CT in Moyamoya patients.
    Rim NJ; Kim HS; Shin YS; Kim SY
    AJNR Am J Neuroradiol; 2008 Oct; 29(9):1658-63. PubMed ID: 18617583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arterial spin-labeling MR imaging in moyamoya disease compared with SPECT imaging.
    Noguchi T; Kawashima M; Irie H; Ootsuka T; Nishihara M; Matsushima T; Kudo S
    Eur J Radiol; 2011 Dec; 80(3):e557-62. PubMed ID: 21315533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral blood flow measurement as an indicator for an indirect revascularization procedure for adult patients with moyamoya disease.
    Kohno K; Oka Y; Kohno S; Ohta S; Kumon Y; Sakaki S
    Neurosurgery; 1998 Apr; 42(4):752-7; discussion 757-8. PubMed ID: 9574639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged Mean Transit Time Detected by Dynamic Susceptibility Contrast Magnetic Resonance Imaging Predicts Cerebrovascular Reserve Impairment in Patients with Moyamoya Disease.
    Kawano T; Ohmori Y; Kaku Y; Muta D; Uekawa K; Nakagawa T; Amadatsu T; Kasamo D; Shiraishi S; Kitajima M; Kuratsu J
    Cerebrovasc Dis; 2016; 42(1-2):131-8. PubMed ID: 27088711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative measurement of regional cerebrovascular reactivity to acetazolamide using 123I-N-isopropyl-p-iodoamphetamine autoradiography with SPECT: validation study using H2 15O with PET.
    Ogasawara K; Ito H; Sasoh M; Okuguchi T; Kobayashi M; Yukawa H; Terasaki K; Ogawa A
    J Nucl Med; 2003 Apr; 44(4):520-5. PubMed ID: 12679394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic evaluation of vascular reconstructive surgery for childhood moyamoya disease using single photon emission computed tomography.
    Takikawa S; Kamiyama H; Abe H; Mitsumori K; Tsuru M
    Neurol Med Chir (Tokyo); 1990 Jun; 30(6):389-95. PubMed ID: 1700318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disappearance of hemichorea as the initial presentation of moyamoya disease after revascularization surgery regardless of residual hypoperfusion evaluated by quantitative N-isopropyl-p-
    Onodera K; Sato H; Lepic M; Suzuki K; Ooigawa H; Kurita H
    Neurochirurgie; 2023 Jul; 69(4):101449. PubMed ID: 37178488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contralateral cerebral hemodynamic changes after unilateral direct revascularization in patients with moyamoya disease.
    Ma Y; Li M; Jiao LQ; Zhang HQ; Ling F
    Neurosurg Rev; 2011 Jul; 34(3):347-53; discussion 353-4. PubMed ID: 21538064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.